Takahiro Yano

Itabashi, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Cell death and wing reduction during the metamorphosis of sex-specific flightless morphs in winter geometrid moths.

Cell death and wing reduction during the metamorphosis of sex-specific flightless morphs in winter geometrid moths.

Journal: Journal of morphology

Published: May 15, 2023

Discordant lymphoma of diffuse large B-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified in a human T-cell leukemia virus type-I carrier

Discordant lymphoma of diffuse large B-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified in a human T-cell leukemia virus type-I carrier

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: October 07, 2021

Importance of Compliance With Guidelines for the Prevention of Varicella-Zoster Virus Reactivation in Multiple Myeloma.

Importance of Compliance With Guidelines for the Prevention of Varicella-Zoster Virus Reactivation in Multiple Myeloma.

Journal: In vivo (Athens, Greece)

Published: June 06, 2021

Phase II study of dose-adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B-cell lymphoma patients.

Phase II study of dose-adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B-cell lymphoma patients.

Journal: EJHaem

Published: September 11, 2020

Safety and Effectiveness of Ixazomib Dose-escalating Strategy in Ixazomib-Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma.

Safety and Effectiveness of Ixazomib Dose-escalating Strategy in Ixazomib-Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma.

Journal: In vivo (Athens, Greece)

Published: May 01, 2020

Evaluation of prognosis following early disease progression in peripheral T-cell lymphoma.

Evaluation of prognosis following early disease progression in peripheral T-cell lymphoma.

Journal: International journal of hematology

Published: February 18, 2020

Occurrence of acquired factor V inhibitor during antibiotic therapy for a surgical wound infection

Occurrence of acquired factor V inhibitor during antibiotic therapy for a surgical wound infection

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: September 07, 2018

R-mini CHP in ≥80-year-old Patients with Diffuse Large B-cell Lymphoma: A Multicenter, Open-label, Single-arm Phase II Trial Protocol.

R-mini CHP in ≥80-year-old Patients with Diffuse Large B-cell Lymphoma: A Multicenter, Open-label, Single-arm Phase II Trial Protocol.

Journal: Acta medica Okayama

Published: June 22, 2018

Clinical characteristics and outcomes of diffuse large B-cell lymphoma in adolescents and young adults.

Clinical characteristics and outcomes of diffuse large B-cell lymphoma in adolescents and young adults.

Journal: International journal of hematology

Published: December 23, 2017

Chronic lymphocytic leukemia: biology, disease progression, and current treatment strategies.

Chronic lymphocytic leukemia: biology, disease progression, and current treatment strategies.

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: October 06, 2017

The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis.

The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis.

Journal: Leukemia & lymphoma

Published: June 09, 2017

Phase II study of intensified rituximab induction and maintenance for low grade B cell lymphoma.

Phase II study of intensified rituximab induction and maintenance for low grade B cell lymphoma.

Journal: Leukemia & lymphoma

Published: May 17, 2017

Showing 1-12 of 25

Last Updated: 09/26/2026